Evidence mapPaperPMID 42226266Full record

ReviewBiology direct2026

Deep learning-driven decoding of ubiquitination: from regulatory mechanisms to targeted protein degradation.

Jiaqi Zhang, Boyu Xia, Zhe Wang, Zhixiong Wang, Yanmei Sun, Han Wang, Xinhao Li, Xin Gao, Weijie Zhao, Yunxin Li and 6 more

Abstract readReview
In one paragraph

Review in Biology direct, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jiaqi Zhang *Hepatopancreatobiliary Center, The Second Affiliated Hospital of Nanjing Medical University, Jiangjiayuan 121, Nanjing, Jiangsu Province, China.
Boyu Xia *Hepatopancreatobiliary Center, The Second Affiliated Hospital of Nanjing Medical University, Jiangjiayuan 121, Nanjing, Jiangsu Province, China.
Zhe Wang *Hepatopancreatobiliary Center, The Second Affiliated Hospital of Nanjing Medical University, Jiangjiayuan 121, Nanjing, Jiangsu Province, China.
Zhixiong WangHepatopancreatobiliary Center, The Second Affiliated Hospital of Nanjing Medical University, Jiangjiayuan 121, Nanjing, Jiangsu Province, China.
Yanmei SunHepatopancreatobiliary Center, The Second Affiliated Hospital of Nanjing Medical University, Jiangjiayuan 121, Nanjing, Jiangsu Province, China.
Han WangHepatopancreatobiliary Center, The Second Affiliated Hospital of Nanjing Medical University, Jiangjiayuan 121, Nanjing, Jiangsu Province, China.
Xinhao LiHepatopancreatobiliary Center, The Second Affiliated Hospital of Nanjing Medical University, Jiangjiayuan 121, Nanjing, Jiangsu Province, China.
Xin GaoHepatopancreatobiliary Center, The Second Affiliated Hospital of Nanjing Medical University, Jiangjiayuan 121, Nanjing, Jiangsu Province, China.
Weijie ZhaoHepatopancreatobiliary Center, The Second Affiliated Hospital of Nanjing Medical University, Jiangjiayuan 121, Nanjing, Jiangsu Province, China.
Yunxin LiHepatopancreatobiliary Center, The Second Affiliated Hospital of Nanjing Medical University, Jiangjiayuan 121, Nanjing, Jiangsu Province, China.
Feilong ZhouHepatopancreatobiliary Center, The Second Affiliated Hospital of Nanjing Medical University, Jiangjiayuan 121, Nanjing, Jiangsu Province, China.
Tianyi ChenHepatopancreatobiliary Center, The Second Affiliated Hospital of Nanjing Medical University, Jiangjiayuan 121, Nanjing, Jiangsu Province, China.
Zonghan ShiHepatopancreatobiliary Center, The Second Affiliated Hospital of Nanjing Medical University, Jiangjiayuan 121, Nanjing, Jiangsu Province, China.
Junxian LvHepatopancreatobiliary Center, The Second Affiliated Hospital of Nanjing Medical University, Jiangjiayuan 121, Nanjing, Jiangsu Province, China.
Ruowei YangHepatopancreatobiliary Center, The Second Affiliated Hospital of Nanjing Medical University, Jiangjiayuan 121, Nanjing, Jiangsu Province, China.
Yewei ZhangHepatopancreatobiliary Center, The Second Affiliated Hospital of Nanjing Medical University, Jiangjiayuan 121, Nanjing, Jiangsu Province, China. zhangyewei@njmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUbiquitination is a highly dynamic post-translational modification that plays central roles in protein homeostasis, signal transduction, immune regulation, and cell fate control. Through the coordinated actions of E3 ubiquitin ligases and deubiquitinating enzymes, ubiquitination shapes the ubiquitin-proteasome system and influences a wide range of physiological and pathological processes. Dysregulation of this system is closely associated with cancer, neurodegenerative disorders, immune dysfunction, and metabolic disease. However, a comprehensive understanding of ubiquitination remains limited because of incomplete annotation, context-dependent regulation, transient molecular interactions, and highly complex many-to-many regulatory networks. MAIN BODY: In this review, we summarize how deep learning is reshaping ubiquitination research at multiple levels. First, we outline the major deep learning architectures applied in this field, including convolutional neural networks, recurrent neural networks, Transformers, protein language models, graph neural networks, generative models, and reinforcement learning. Second, we review recent progress in predicting ubiquitination sites and ubiquitin chain-related features, with emphasis on sequence-based, structure-informed, and multimodal representation learning strategies. Third, we discuss how deep learning contributes to mechanistic decoding of ubiquitination specificity, including substrate recognition by E3 ubiquitin ligases and deubiquitinating enzymes, degron identification, and the organization of ubiquitination regulatory networks. Fourth, we highlight the translational relevance of these approaches in biomarker discovery, targeted protein degradation, molecular glue discovery, degrader optimization, and ubiquitin-centered therapeutic design. Collectively, these advances show that deep learning is not only improving predictive accuracy, but also enhancing mechanistic interpretability and enabling rational molecular design.

conclusionDeep learning is driving ubiquitination research from descriptive prediction toward mechanistic understanding and therapeutic application. Future progress will depend on developing more interpretable models, integrating physiological context, and strengthening experimental validation. Such efforts will accelerate the translation of ubiquitin biology into clinically useful biomarkers, precision diagnostics, and targeted therapies.

Indexed as

Deep LearningProteolysisUbiquitinationAnimalsHumansProtein Processing, Post-TranslationalDeep learningDegronE3 ubiquitin ligaseMolecular designProtein language modelTargeted protein degradationUbiquitinationUbiquitin–proteasome system

Identifiers

PMID42226266
PMCPMC13455158

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.